Inspire Medical Systems (INSP) Stock Price, News & Analysis

Company Overview

Inspire Medical Systems, Inc. is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve. The device received FDA approval in 2014 and has since obtained CE mark authorization for marketing in Europe. Inspire collaborates with a network of accredited sleep centers and specialized physicians to identify eligible patients and provide training, support and follow-up care.

Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems serves markets across North America and Europe, with ongoing efforts to expand its commercial footprint in select international regions. The company is led by President and Chief Executive Officer Michael A. Moulder, supported by a management team with deep expertise in medical devices, regulatory affairs and commercial operations. Inspire remains focused on advancing its technology platform through clinical research, product enhancements and expanded physician education programs.

Key Stats

• Today's Range: $57.00 to $58.14
• 50-Day Range: $41.08 to $64.08
• 52-Week Range: $38.91 to $147.03
• Volume: 656,572 shs
• Average Volume: 812,298 shs
• Market Capitalization: $1.66 billion
• P/E Ratio: 12.43
• Dividend Yield: N/A
• Price Target: $66.19
• Consensus Rating: Hold

Inspire Medical Systems Stock Analysis - MarketRank™

Inspire Medical Systems scored higher than 83% of companies evaluated by MarketBeat, and ranked 104th out of 909 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Hold

Consensus Rating

Inspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on 1 strong buy rating, 3 buy ratings, 12 hold ratings, and 3 sell ratings.

Upside Potential

Inspire Medical Systems has a consensus price target of $66.19, representing about 15.3% upside from its current price of $57.43.

Amount of Analyst Coverage

Inspire Medical Systems has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 22.58%

Earnings Growth

Earnings for Inspire Medical Systems are expected to grow by 22.58% in the coming year, from $1.24 to $1.52 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Inspire Medical Systems is 12.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.29.

Price to Earnings Ratio vs. Sector

The P/E ratio of Inspire Medical Systems is 12.43, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 270.31.

Price to Earnings Growth Ratio

Inspire Medical Systems has a PEG Ratio of 4.34. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Inspire Medical Systems has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

13.87% of the float of Inspire Medical Systems has been sold short.

Short Interest Ratio / Days to Cover

Inspire Medical Systems has a short interest ratio ("days to cover") of 5.02.

Change versus previous month

Short interest in Inspire Medical Systems has recently decreased by 9.77%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Inspire Medical Systems does not currently pay a dividend.

Dividend Growth

Inspire Medical Systems does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 1.03

News Sentiment

Inspire Medical Systems has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Inspire Medical Systems this week, compared to 9 articles on an average week.

MarketBeat Follows

5 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,347.00 in company stock.

Percentage Held by Insiders

2.20% of the stock of Inspire Medical Systems is held by insiders.

Percentage Held by Institutions

94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/03/2026
• Today: 8/18/2026
• Next Earnings (Estimated): 11/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:INSP
• CIK: 1609550
• Web: www.inspiresleep.com
• Phone: (844) 672-4357
• Fax: N/A
• Employees: 1,333
• Year Founded: 2007

Price Target and Rating

• Average Price Target for Inspire Medical Systems: $66.19
• High Price Target: $180.00
• Low Price Target: $39.00
• Potential Upside/Downside: +15.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.11
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.62
• Trailing P/E Ratio: 12.43
• Forward P/E Ratio: 46.31
• P/E Growth: 4.34
• Net Income: $145.42 million
• Net Margins: 15.03%
• Pretax Margin: 7.72%
• Return on Equity: 8.64%
• Return on Assets: 7.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.55
• Quick Ratio: 6.16

Sales & Book Value

• Annual Sales: $911.98 million
• Price / Sales: 1.82
• Cash Flow: $2.88 per share
• Price / Cash Flow: 19.94
• Book Value: $26.88 per share
• Price / Book: 2.14

Miscellaneous

• Outstanding Shares: 28,910,000
• Free Float: 28,274,000
• Market Cap: $1.66 billion
• Optionable: Optionable
• Beta: 0.70